Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. health programs
Show results for

Refine by

Health Programs Articles & Analysis

128 news found

Bayer completes acquisition of Blackford Analysis Ltd.

Bayer completes acquisition of Blackford Analysis Ltd.

The collaboration with Bayer has its roots in 2019, when Blackford was among the selected start-ups of Bayer’s G4A Digital Health Partnerships Program that year. About Radiology at Bayer As a true life-science company with a heritage of over 100 years in Radiology, Bayer is committed to providing excellence, from innovative products to high-quality ...

ByBayer AG


Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

“This acquisition complements our comprehensive radiology portfolio and nourishes our engagement to drive innovation in digital health. We are pleased to join forces with Blackford and their exceptional team to optimally utilize our combined expertise in healthcare technology with the aim to deliver true value to radiologists and their teams for the benefit of their ...

ByBayer AG


Apollo Medical Holdings, Inc. Receives NCQA`s HEDIS Health Plan Measure Certification for Measurement Year 2022

Apollo Medical Holdings, Inc. Receives NCQA`s HEDIS Health Plan Measure Certification for Measurement Year 2022

ApolloMed was certified by the NCQA HEDIS Health Plan Measure Certification Program™ for the measurement year 2022. This year's certified measures include Hemoglobin A1c Control for Patients with Diabetes (HBD), Blood Pressure Control for Patients with Diabetes (BPD), Kidney Health Evaluation for Patients with Diabetes (KED), Lead Screening ...

ByApollo Medical Holdings, Inc.


Enterprise Forum

Enterprise Forum

You will no longer have to wait for days for a central diagnostic laboratory to provide critical medical test data regarding your health. This program showcases a range of young diagnostic companies that are poised to launch exciting products and services that will truly change your ...

ByAffinity Biosensors


Daily Inspiration: Meet Gillian Henker

Daily Inspiration: Meet Gillian Henker

With her parents and sister being nurses, Gillian was inspired to pursue a career in Global Health Engineering. She was one of the first students at the University of Michigan to be a part of the Global Health Engineering program that Professor Sienko created. Following graduation, Gillian and fellow engineers created DIIME, Design Innovations ...

BySisu Global Health


Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

(DOI: 10.1038/s41541-022-00534-5) The NIH has renewed funding for the research program as a Phase 2 STTR. The renewed funding will help to move the vaccine closer to human clinical trials. ...

ByLumen Bioscience, Inc.


Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone

Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone

Zuranolone is being evaluated in the LANDSCAPE and NEST clinical development programs. The two development programs include multiple studies examining use of zuranolone in several thousand people with a variety of dosing, clinical endpoints, and treatment paradigms. ...

BySage Therapeutics


Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector

Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector

Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...

ByAktiv Pharma Group, Inc


PatientPoint and Susan G. Komen Launch Point-of-Care Campaign to Help Improve Breast Cancer Outcomes in the Black Community

PatientPoint and Susan G. Komen Launch Point-of-Care Campaign to Help Improve Breast Cancer Outcomes in the Black Community

Komen®Stand for H.E.R—a Health Equity Revolution program by bringing point-of-care breast health resources to patients and healthcare providers in U.S. metropolitan areas where breast cancer mortality gaps are greatest between Black and white women. ...

ByPatientPoint, LLC


Alveo Technologies Expands Scientific Advisory Board with Appointment of Esteemed Healthcare Business Executive, Fran Soistman

Alveo Technologies Expands Scientific Advisory Board with Appointment of Esteemed Healthcare Business Executive, Fran Soistman

Fran’s expertise in the business of healthcare will provide Alveo with the necessary insights to put the be.well™ platform in the hands of clinicians as quickly as possible to contain infectious diseases and avoid future public health crises.” Soistman brings to Alveo’s SAB more than 40 years of diverse experience in healthcare and managed care. In his ...

ByAlveo Technologies


Daxor’s Blood Volume Analyzer (BVA-100) to Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients

Daxor’s Blood Volume Analyzer (BVA-100) to Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today participation in the National Institutes of Health (NIH) Intramural Research Program-sponsored study titled “An Observational Study of Neurologic Function after COVID-19 Infection” utilizing Daxor’s BVA-100 (Blood Volume Analyzer, ...

ByDaxor Corporation


Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants

Vertex Announces $50 Million Commitment to Health Equity With Three Initial Grants

The donations are an extension of Vertex’s long-standing commitment to inclusion, diversity and equity and the existing work of the Vertex Foundation to promote these values through education, innovation and various health programs. “We’re delighted to be working with Year Up, JDRF and the Massachusetts General Hospital, along with a number of ...

ByVertex Pharmaceuticals


Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology

About Tetra Bio-Pharma Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. ...

ByTetra Bio-Pharma


Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding

Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding

Neuropathix wholly owned subsidiary, Kannalife Sciences, Inc. received a $2.97 million grant from the National Institutes of Health HEAL program for IND enabling studies and the furtherment of its clinical program for KLS-13019. ...

ByNeuropathix, Inc.


Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink Therapy

Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink Therapy

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has commenced a Phase 2 clinical program for its third-generationiLink™ therapy designed to treat keratoconus. ...

ByGlaukos Corporation


Omega Medical Imaging Announces Installation of AI Image-Guided Interventional Endoscopy Systems at Orlando Health

Omega Medical Imaging Announces Installation of AI Image-Guided Interventional Endoscopy Systems at Orlando Health

Varadarajulu, MD, President, Orlando Health Digestive Health Institute. “We have designed a truly unique program.” “Omega is excited to be part of Orlando Health’s new state-of-the-art digestive health program,” said President and CEO of Omega Medical Imaging. ...

ByOmega Medical Imaging, LLC.


Imbed’s Microlyte Matrix Added to VA’S IDIQ Contract

Imbed’s Microlyte Matrix Added to VA’S IDIQ Contract

The approval makes this innovative technology readily available for order by any clinician or administrator at any VA facility nationwide,” said Vince Proffitt, President and CEO of Spartan Medical. ? The Veterans Health Administration (VHA) is the largest integrated health care system in the US, providing care at nearly 1,300 healthcare facilities to ...

ByImbed Biosciences


LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness

More than 3,000 HJF teammates ensure HJF is a trusted and responsive partner by providing scientific, administrative, and program operations services to researchers in the military, academia, and private industry. ...

ByLightDeck Diagnostics


Aidoc Partners With Novant Health, Providing Imaging Ai To Expedite Treatment For Patients In The Emergency Department

Aidoc Partners With Novant Health, Providing Imaging Ai To Expedite Treatment For Patients In The Emergency Department

With a dedication to digital transformation for improving workflow efficiencies and patient outcomes, Novant Health is one of the first health networks in North Carolina to adopt Aidoc’s AI platform. Novant Health has integrated multiple technologies and has been recognized by the College of Healthcare Information Management ...

ByAidoc


Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units

Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units

About Tetra Bio-Pharma Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. ...

ByTetra Bio-Pharma

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT